Dual stem cell and anti-aging therapy extends mouse lifespan by over 70% (opens in new tab)

Immorta Bio and TAM Global announced a preclinical collaboration that, according to the company, produced a more than 70 percent increase in lifespan in mice. The study tested a dual-modality approach pairing SenoVax, an immune-based therapy intended to selectively clear senescent cells, with StemCellRevivify, a personalized mesenchymal stem cell platform designed to restore tissue function. […] The post appeared first on <a href="